诚信认证:
工商注册信息已核实!
![](https://img.antpedia.com/cbook/dist_templates/0/images/icon04.png)
![](https://cbook.antpedia.com/attachments/design/6751/1577268752-5396.png)
AM966
品牌 | 厂商性质 | 产地 | 货期 |
---|---|---|---|
阿拉丁 | 生产商 | 上海 | 现货 |
货号 | CAS号 | 操作 |
---|---|---|
A125594-10mg | 1228690-19-4 | 询价 |
A125594-50mg | 1228690-19-4 | 询价 |
A125594-5mg | 1228690-19-4 | 询价 |
属性
溶解性 | DMSO |
存贮条件 | 储存温度-20°C |
描述
产品介绍 | AM966是高亲和性的口服的溶血磷脂酸(LPA1)受体拮抗剂,IC50为17 nM,比对其它LPA受体的抑制性高。 |
生化机理 |
AM966 is a high affinity, selective, oral LPA1 (lysophosphatidic acid receptor) antagonist, with selectivity for this receptor over the other LPA receptors. In vitro, AM966 inhibited LPA-stimulated intracellular calcium release (IC(50)= 17 nM) from Chinese hamster ovary cells stably expressing human LPA(1) receptors and inhibited LPA-induced chemotaxis (IC(50)= 181 nM) of human IMR-90 lung fibroblasts expressing LPA(1) receptors. AM966 demonstrated a good pharmacokinetic profile following oral dosing in mice. In the mouse, AM966 reduced lung injury, vascular leakage, inflammation and fibrosis at multiple time points following intratracheal bleomycin instillation. AM966 also decreased lactate dehydrogenase activity and tissue inhibitor of metalloproteinase-1, transforming growth factor beta1, hyaluronan and matrix metalloproteinase-7, in bronchoalveolar lavage fluid. Anti-inflammatory agents. |
别名 | 4'-(4-((((1R)-1-(2-氯苯基)乙氧基)羰基)氨基)-3-甲基-5-异恶唑基)-联苯-4-乙酸;;AM 966;AM-966; 4'-(4-((((1r)-1-(2-chlorophenyl)ethoxy)carbonyl)amino)-3-methyl-5-isoxazolyl)-(1,1'-biphenyl)-4-acetic acid; |
AM966信息由上海阿拉丁生化科技股份有限公司为您提供,如您想了解更多关于AM966报价、型号、参数等信息,欢迎来电或留言咨询。
注:该产品未在中华人民共和国食品药品监督管理部门申请医疗器械注册和备案,不可用于临床诊断或治疗等相关用途